SCHEMBL2747232

SCHEMBL2747232

O=C(O)Cc1cc2c([nH]c1=O)CCCCCC2

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.59
HSD17B10 Q99714 4/20 0.59
ALDH1A1 P00352 3/20 0.59
HPGD P15428 3/20 0.59
NPSR1 Q6W5P4 1/20 0.46
POLB P06746 1/20 0.42
HRH4 Q9H3N8 1/20 0.41
ALOX15 P16050 4/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
RXRA P19793 2/20 0.36
RXRB P28702 2/20 0.36
MAPT P10636 2/20 0.36
ALOX12 P18054 2/20 0.36
TSHR P16473 2/20 0.36
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32662010 0.80 ALDH1A1 (0.57) KDM4EHSD17B10ALDH1A1HPGDNPSR1
SCHEMBL23090378 0.77 KDM4E (0.96) KDM4EHSD17B10ALDH1A1HPGDNPSR1
SCHEMBL22016185 0.75 ALDH1A1 (0.50) KDM4EHSD17B10ALDH1A1HPGDNPSR1
SCHEMBL17675575 0.75 KDM4E (1.00) KDM4EHSD17B10ALDH1A1HPGDNPSR1
SCHEMBL29198801 0.73 KDM4E (0.49) KDM4EHSD17B10ALDH1A1HPGDNPSR1
SCHEMBL21785278 0.73 ALDH1A1 (0.56) KDM4EHSD17B10ALDH1A1HPGDNPSR1
SCHEMBL26755843 0.73 ALDH1A1 (0.56) KDM4EHSD17B10ALDH1A1HPGDNPSR1
SCHEMBL21785590 0.73 ALDH1A1 (0.56) KDM4EHSD17B10ALDH1A1HPGDNPSR1
Hydrochloric Acid SCHEMBL30705688 0.73 KDM4E (0.49) KDM4EHSD17B10ALDH1A1HPGDNPSR1
SCHEMBL31376415 0.72 KDM4E (0.70) KDM4EHSD17B10ALDH1A1HPGDNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1806342-B1 3-CARBAMOYL-2-PYRIDONE DERIVATIVE SHIONOGI & CO (JP) 2013-04-17 EP disclosed
US-8367666-B2 3-carbamoyl-2-pyridone derivatives SHIONOGI & CO., LTD. (JP) 2013-02-05 US disclosed
US-20120208813-A1 3-CARBAMOYL-2-PYRIDONE DERIVATIVES SHIONOGI & CO., LTD. 2012-08-16 US disclosed
US-8178681-B2 methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency SHIONOGI & CO., LTD. (JP) 2012-05-15 US disclosed
US-20080103139-A1 3-Carbamoyl-2-Pyridone Derivative SHIONOGI & CO. LTD. (JP) 2008-05-01 US disclosed
EP-1806342-A1 3-CARBAMOYL-2-PYRIDONE DERIVATIVE SHIONOGI & CO., LTD. (JP) 2007-07-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120208813-A1 3-CARBAMOYL-2-PYRIDONE DERIVATIVES CNR2, CNR1, HRH4 KDM4E 1326/4885HSD17B10 2220/4885ALDH1A1 3505/4885
US-20080103139-A1 3-Carbamoyl-2-Pyridone Derivative CNR1, CNR2, HRH4 KDM4E 1522/4885HSD17B10 1887/4885ALDH1A1 4132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.